Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.

[1]  A. Fontanet,et al.  Maternal age at first childbirth and geographical variation in HBV prevalence in Cameroon: Important role of mother-to-child transmission. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation , 2021, Nucleic Acids Res..

[3]  R. Chou,et al.  Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[4]  R. Chou,et al.  Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[5]  C. Lefeuvre,et al.  Evaluation of the Aptima™ HBV Quant Dx assay for semi-quantitative HBV viral load from dried blood spots. , 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. Buti,et al.  Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  M. Lemoine,et al.  Mother‐to‐child transmission of hepatitis B: What more needs to be done to eliminate it around the world? , 2019, Journal of viral hepatitis.

[8]  P. Vanhems,et al.  Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study , 2019, PloS one.

[9]  Minal K. Patel,et al.  Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries , 2018, Journal of immunological sciences.

[10]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[11]  Mathias Vandenbogaert,et al.  Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples , 2018, PloS one.

[12]  R. Tohme,et al.  The status of hepatitis B control in the African region , 2017, The Pan African medical journal.

[13]  J. Bigna,et al.  Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis , 2017, BMJ Open.

[14]  Xiaofeng Liang,et al.  Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China , 2017, Emerging infectious diseases.

[15]  A. Funk,et al.  Systematic review with meta‐analysis: the risk of mother‐to‐child transmission of hepatitis B virus infection in sub‐Saharan Africa , 2016, Alimentary pharmacology & therapeutics.

[16]  A. Zanetti,et al.  Hepatitis B vaccination , 2015, Human vaccines & immunotherapeutics.

[17]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[18]  J. Ward,et al.  CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[19]  J. Huraux,et al.  High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North Cameroon , 2013, PloS one.

[20]  A. Hall,et al.  Association of Early Age at Establishment of Chronic Hepatitis B Infection with Persistent Viral Replication, Liver Cirrhosis and Hepatocellular Carcinoma: A Systematic Review , 2013, PloS one.

[21]  H. Whittle,et al.  Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose , 2013, PloS one.

[22]  H. Hsu,et al.  Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. , 2012, Gastroenterology.

[23]  Roger Y Dodd,et al.  Nucleic acid testing to detect HBV infection in blood donors. , 2011, The New England journal of medicine.

[24]  B. Gessner,et al.  A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire. , 2008, Vaccine.

[25]  C. Gibbs,et al.  Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. , 2003, Journal of hepatology.

[26]  S. Marion,et al.  Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. , 1994, American journal of epidemiology.

[27]  H. Inskip,et al.  The pattern of childhood hepatitis B infection in two Gambian villages. , 1990, The Journal of infectious diseases.